AU2001255322A1 - Method for treating a patient with neoplasia by treatment with a topoisomerase iinhibitor - Google Patents

Method for treating a patient with neoplasia by treatment with a topoisomerase iinhibitor

Info

Publication number
AU2001255322A1
AU2001255322A1 AU2001255322A AU5532201A AU2001255322A1 AU 2001255322 A1 AU2001255322 A1 AU 2001255322A1 AU 2001255322 A AU2001255322 A AU 2001255322A AU 5532201 A AU5532201 A AU 5532201A AU 2001255322 A1 AU2001255322 A1 AU 2001255322A1
Authority
AU
Australia
Prior art keywords
iinhibitor
neoplasia
topoisomerase
patient
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255322A
Inventor
Joseph Lobacki
Rifat Pamukcu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Pathways Inc
Original Assignee
Cell Pathways Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Pathways Inc filed Critical Cell Pathways Inc
Publication of AU2001255322A1 publication Critical patent/AU2001255322A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU2001255322A 2000-04-12 2001-04-12 Method for treating a patient with neoplasia by treatment with a topoisomerase iinhibitor Abandoned AU2001255322A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54813500A 2000-04-12 2000-04-12
US09548135 2000-04-12
PCT/US2001/011865 WO2001078651A2 (en) 2000-04-12 2001-04-12 Method for treating neoplasmin with topoisomase i inhibitor

Publications (1)

Publication Number Publication Date
AU2001255322A1 true AU2001255322A1 (en) 2001-10-30

Family

ID=24187563

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255322A Abandoned AU2001255322A1 (en) 2000-04-12 2001-04-12 Method for treating a patient with neoplasia by treatment with a topoisomerase iinhibitor

Country Status (3)

Country Link
EP (1) EP1278519A4 (en)
AU (1) AU2001255322A1 (en)
WO (1) WO2001078651A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535148A (en) * 2000-06-06 2003-11-25 グラクソ グループ リミテッド How to treat cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604233A (en) * 1994-04-28 1997-02-18 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof
US6063818A (en) * 1996-06-13 2000-05-16 Cell Pathways Inc. Substituted benzylidene indenyl formamides, acetamides and propionamides
AU754864B2 (en) * 1998-03-28 2002-11-28 Arizona Board Of Regents On Behalf Of The University Of Arizona, The DFMO and sulindac combination in cancer chemoprevention
US6200771B1 (en) * 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia

Also Published As

Publication number Publication date
EP1278519A2 (en) 2003-01-29
WO2001078651A2 (en) 2001-10-25
WO2001078651A3 (en) 2002-03-14
EP1278519A4 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
AU1624400A (en) Method for treating a patient with neoplasia by treatment with a platinum coordination complex
AU2001231104A1 (en) Methods for treating diabetes
AU2002215125A1 (en) Well treatment method
AU2001282717A1 (en) Cancer treatment by combination therapy
AU2002221387A1 (en) Sensor for a water treatment apparatus
AU2002232919A1 (en) Method for treating fibrotic diseases or other indications
AU2001239858A1 (en) Wastewater treatment process
AUPQ533700A0 (en) Soil treatment method
AU2149500A (en) Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
AU2002217447A1 (en) Apparatus for lipolysis for aesthetic treatment
AU751887B2 (en) Guide bar including stump treatment
AU9716001A (en) Guide bar including stump treatment
AU2001255322A1 (en) Method for treating a patient with neoplasia by treatment with a topoisomerase iinhibitor
AU2001238609A1 (en) Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
AU2002225327A1 (en) Apparatus for aesthetic treatment
AU2001269422A1 (en) A method for treating celiac disease
GB0026838D0 (en) Treatment method
AU5421200A (en) A body treatment apparatus
AU2924400A (en) Plant treatment method
AU1475500A (en) Method for treating a patient with neoplasia by treatment with a pyrimidine analog
EP1131076A4 (en) Method for treating a patient with neoplasia by treatment with an anthracycline antibiotic
AUPQ909100A0 (en) A method for diagnosis and treatment
AU2002212876A1 (en) Method for integrated water treatment
AU2001241913A1 (en) Methods for wound treatment
AU2001275515A1 (en) Method for treating hyperglycemia